• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.

作者信息

Padfield Gareth J, AlAhmari Leenah, Lieve Krystien V V, AlAhmari Tasneem, Roston Thomas M, Wilde Arthur A, Krahn Andrew D, Sanatani Shubhayan

机构信息

Heart Rhythm Services, University of British Columbia, Vancouver, British Columbia, Canada.

The Heart Centre, Department of Clinical and Experimental Cardiology, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Heart Rhythm. 2016 Feb;13(2):609-13. doi: 10.1016/j.hrthm.2015.09.027. Epub 2015 Sep 28.

DOI:10.1016/j.hrthm.2015.09.027
PMID:26416620
Abstract
摘要

相似文献

1
Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.对于某些对β受体阻滞剂不耐受的儿茶酚胺能多形性室性心动过速患者，氟卡尼单药治疗是一种选择。
Heart Rhythm. 2016 Feb;13(2):609-13. doi: 10.1016/j.hrthm.2015.09.027. Epub 2015 Sep 28.
2
Wide Complex Tachycardia in a Patient With a History of Atrial Fibrillation.一名有房颤病史患者的宽QRS波心动过速
JAMA Intern Med. 2016 Mar;176(3):386-8. doi: 10.1001/jamainternmed.2015.7605.
3
Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis.氟卡尼治疗儿茶酚胺能多形性室性心动过速患者的安全性和有效性：一项系统评价和荟萃分析。
Medicine (Baltimore). 2019 Aug;98(34):e16961. doi: 10.1097/MD.0000000000016961.
4
Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.氟卡尼对儿茶酚胺多形性室性心动过速基因型阴性患者运动诱发室性心律失常和复发的影响。
Heart Rhythm. 2013 Apr;10(4):542-7. doi: 10.1016/j.hrthm.2012.12.035. Epub 2012 Dec 31.
5
Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia.
Europace. 2011 Jan;13(1):129-30. doi: 10.1093/europace/euq279. Epub 2010 Aug 26.
6
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.氟卡尼治疗可抑制 CASQ2 相关儿茶酚胺敏感性多形性室性心动过速患者运动诱发的室性心律失常。
Heart Rhythm. 2013 Nov;10(11):1671-5. doi: 10.1016/j.hrthm.2013.08.011. Epub 2013 Aug 13.
7
In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速药物治疗的计算机模拟预测
J Physiol. 2016 Feb 1;594(3):567-93. doi: 10.1113/JP271282. Epub 2015 Dec 30.
8
Long-term flecainide therapy in type 3 long QT syndrome.3 型长 QT 综合征的长期氟卡尼治疗。
Europace. 2018 Feb 1;20(2):370-376. doi: 10.1093/europace/euw439.
9
A Focus on Pharmacological Management of Catecholaminergic Polymorphic Ventricular Tachycardia.关注儿茶酚胺能多形性室性心动过速的药物治疗
Mini Rev Med Chem. 2018;18(6):476-482. doi: 10.2174/1389557517666170707100923.
10
Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia.纳多洛尔比β1 选择性β受体阻滞剂在儿茶酚胺多形性室性心动过速患者运动压力测试中降低室性心律失常的发生率和严重程度。
Heart Rhythm. 2016 Feb;13(2):433-40. doi: 10.1016/j.hrthm.2015.09.029. Epub 2015 Sep 30.

引用本文的文献

1
Pharmacological Enhancement of Small Conductance Ca-Activated K Channels Suppresses Cardiac Arrhythmias in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia.小电导钙激活钾通道的药理学增强可抑制儿茶酚胺能多形性室性心动过速小鼠模型中的心律失常。
Circ Res. 2025 May 29. doi: 10.1161/CIRCRESAHA.124.325477.
2
Cardiac Channelopathies: Clinical Diagnosis and Promising Therapeutics.心脏离子通道病：临床诊断与前景广阔的治疗方法
J Am Heart Assoc. 2025 May 6;14(9):e040072. doi: 10.1161/JAHA.124.040072. Epub 2025 Apr 25.
3
Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement of the European Heart Rhythm Association of the ESC.
抗心律失常药物实用手册：欧洲心脏病学会（ESC）欧洲心律协会临床共识声明
Europace. 2025 Mar 30. doi: 10.1093/europace/euaf076.
4
[Cardiac channelopathies in the context of hereditary arrhythmia syndromes].[遗传性心律失常综合征背景下的心脏离子通道病]
Inn Med (Heidelb). 2024 Aug;65(8):787-797. doi: 10.1007/s00108-024-01751-x. Epub 2024 Jul 8.
5
Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies.儿茶酚胺能多形性室性心动过速：临床特征、诊断评估与治疗策略
J Clin Med. 2024 Mar 20;13(6):1781. doi: 10.3390/jcm13061781.
6
Inherited Arrhythmias in the Pediatric Population: An Updated Overview.儿科人群遗传性心律失常：最新概述。
Medicina (Kaunas). 2024 Jan 3;60(1):94. doi: 10.3390/medicina60010094.
7
Catecholaminergic Polymorphic Ventricular Tachycardia.儿茶酚胺能多形性室性心动过速
Arrhythm Electrophysiol Rev. 2022 Apr;11:e20. doi: 10.15420/aer.2022.09.
8
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2020年心律失常药物治疗指南》
J Arrhythm. 2022 Oct 25;38(6):833-973. doi: 10.1002/joa3.12714. eCollection 2022 Dec.
9
The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia.氟卡尼在儿茶酚胺能多形性室性心动过速中的抗心律失常机制
Front Physiol. 2022 Mar 9;13:850117. doi: 10.3389/fphys.2022.850117. eCollection 2022.
10
Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: A Translational Perspective for the Clinician-Scientist.儿科儿茶酚胺多形性室性心动过速：临床科学家的转化视角。
Int J Mol Sci. 2021 Aug 27;22(17):9293. doi: 10.3390/ijms22179293.